Advertisement
Singapore markets open in 5 hours 50 minutes

  • Straits Times Index

    3,439.88
    +24.37 (+0.71%)
     

  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     

  • Dow

    39,308.00
    -23.90 (-0.06%)
     

  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     

  • Bitcoin USD

    58,252.80
    -1,802.48 (-3.00%)
     

  • CMC Crypto 200

    1,211.10
    -50.08 (-3.97%)
     

  • FTSE 100

    8,241.26
    +70.14 (+0.86%)
     

  • Gold

    2,369.40
    0.00 (0.00%)
     

  • Crude Oil

    84.06
    +0.18 (+0.21%)
     

  • 10-Yr Bond

    4.3550
    0.0000 (0.00%)
     

  • Nikkei

    40,913.65
    +332.89 (+0.82%)
     

  • Hang Seng

    18,028.28
    +49.71 (+0.28%)
     

  • FTSE Bursa Malaysia

    1,616.75
    +1.43 (+0.09%)
     

  • Jakarta Composite Index

    7,220.89
    +24.13 (+0.34%)
     

  • PSE Index

    6,507.49
    +57.46 (+0.89%)
     

Devonian Health Group Third Quarter 2024 Earnings: CA$0.002 loss per share (vs CA$0.011 loss in 3Q 2023)

editorial-team@simplywallst.com (Simply Wall St)
·1-min read

Devonian Health Group (CVE:GSD) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CA$5.13m (up by CA$4.72m from 3Q 2023).

  • Net loss: CA$373.8k (loss narrowed by 75% from 3Q 2023).

  • CA$0.002 loss per share (improved from CA$0.011 loss in 3Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Devonian Health Group shares are up 39% from a week ago.

Risk Analysis

We should say that we've discovered 4 warning signs for Devonian Health Group (2 are a bit unpleasant!) that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com